The antibiotic minocycline increases the lifespan of aged roundworms and prevents the buildup of proteins, revealing a protective mechanism that could be exploited therapeutically to help prevent neurodegenerative diseases.
Now, scientists at Scripps Research have found that minocycline can increase the lifespan of roundworms by preventing the buildup of proteins during aging, according to a study in the open-access journal eLife reports.
Protein aggregation causes several progressive age-related brain diseases, including amyotrophic lateral sclerosis, Alzheimer’s, Parkinson’s and prion diseases. The Scripps Research study shows that minocycline prevents this buildup even in older animals with age-impaired stress-response pathways.
The number of proteins in a cell is balanced by the rate of protein manufacture and disposal, called proteostasis. As we age, proteostasis becomes impaired.
“It would be great if there were a way to enhance proteostasis and extend lifespan and health, by treating older people at the first sign of neurodegenerative symptoms or disease markers such as protein build-up,” says lead author Gregory Solis, a graduate student at Scripps Research. “In this study, we investigated whether minocycline can reduce protein aggregation and extend lifespan in animals that already have impaired proteostasis.”
The team first tested 21 different molecules known to extend lifespan in young and old Caenorhabditis elegans (C. elegans) worms. They found that all of these molecules prolonged the lives of young worms, however, the only drug that worked on the older worms was minocycline.
To find out why, the researchers looked at whether minocycline had any effect on protein aggregation in the worms. They treated young and old worms with water or minocycline and then measured two proteins, ?-synuclein and amyloid-?, which are known to build up in Parkinson’s and Alzheimer’s, respectively. Regardless of the worms’ age, those treated with minocycline had reduced aggregation of both proteins as they grew older.
The team next turned their attention to the mechanism behind this discovery. First, they looked at whether minocycline switches on stress-signaling proteins that are impaired in older worms, but they found the drug actually reduces their activity. Next, they studied whether it turns off the cell’s protein-disposal processes, but this was not its mode of action either.
When researchers used a chemical probe to see how minocycline affects the major protein-regulating molecules in the cell, it revealed that minocycline directly affects the protein-manufacturing machinery of the cell, known as the ribosome. This was true in worms, as well as in mouse and human cells.
Finally, the team used worms with increased or decreased protein-manufacturing activity and studied how this altered the effect of minocycline on protein levels and lifespan. As predicted, in mutant worms where protein manufacturing was already decreased, they found a lower dose of minocycline was needed to further reduce protein levels and extend lifespan. In worms where protein manufacturing was increased, the opposite was seen. This suggested that minocycline extends lifespan by controlling the rate of protein manufacturing at the ribosome.
“We have identified minocycline as a drug that can extend lifespan and improve protein balance in already-aging worms,” says Michael Petrascheck, PhD, senior author of the paper and associate professor at Scripps Research. “Our study reveals how minocycline prevents protein aggregation and lays the foundations for drug development efforts aimed at optimizing this already-approved drug for a range of neurodegenerative diseases.”
The Latest on: Minocycline
via Google News
The Latest on: Minocycline
- Minocycline Hydrochloride Market Size, Share and Demand Forecast to 2025| Hovione, CIPAN, HISUNon August 13, 2019 at 6:10 am
The global Minocycline Hydrochloride market is comprehensively analyzed in the report with the main objective of providing accurate market data and useful recommendations to help players to gain ...
- Insights Into the Global Minocycline Hydrochloride Market 2019-2029| Euticals, Hovione and CIPANon July 31, 2019 at 5:32 am
According to a newly published report by market.us, “Worldwide Minocycline Hydrochloride Market: Information About Key Drivers, Restraints, And Opportunities 2019-2029“. The prime objective of the ...
- Can minocycline help treat rheumatoid arthritis?on July 10, 2019 at 5:09 pm
Healthline Media, Inc. would like to process and share personal data (e.g., mobile ad id) and data about your use of our site (e.g., content interests) with our third party partners (see a current ...
- Common acne drug could prevent artery hardeningon June 11, 2019 at 9:07 am
The new findings reveal that it also promotes calcification in arteries. The researchers also found that the antibiotic minocycline can prevent artery hardening by blocking PAR-triggered calcification ...
- Global Minocycline Hydrochloride Market Status, Type, Consumption by Region, Industry Growth and Forecast Till 2028on April 22, 2019 at 7:14 pm
Apr 23, 2019 (WiredRelease via COMTEX) -- Market.us Explore recently announces that research report on “Global Minocycline Hydrochloride Market By Type (Pharmaceutical Grade, and Industry Grade), By ...
- Minocycline Hydrochloride Market Report Highlights the Competitive Scenario with Impact of Drivers And Challengeson April 19, 2019 at 11:06 am
Global Minocycline Hydrochloride Market Report provides main statistics connected to the overall market and value forecast over a period, from 2019 to 2028. This research report studies minocycline ...
- Minocycline for Acne Changes Skin Microbiotaon February 15, 2019 at 2:51 pm
Antibiotic therapy for acne was linked with variations in the skin microbiota, some of which persisted and weren't necessarily healthy, a four-patient longitudinal study indicated. The tetracycline ...
- Global Minocycline Hydrochloride Market Analysis and Growth Forecast by Applications, Sales, Size, Types and Competitors by 2028on February 6, 2019 at 8:07 pm
Feb 07, 2019 (WiredRelease via COMTEX) -- Market.us adds a new market research report on “Global Minocycline Hydrochloride Market By Type (Pharmaceutical Grade, and Industry Grade), By Application ...
- Antibiotic could protect against neurodegenerative diseases during agingon November 28, 2018 at 8:06 am
An antibiotic, minocycline, can increase the lifespan of roundworms by preventing the build-up of proteins during aging, a study in the open-access journal eLife reports. Protein aggregation causes ...
- Antibiotic may slow or prevent Alzheimer's, Parkinson's, study sayson November 27, 2018 at 4:00 pm
28 (UPI) --A new antibiotic could bring hope to people suffering from Alzheimer's and Parkinson's. After testing the effects of the antibiotic minocycline on older roundworms that had a build-up of ...
via Bing News